Genetic and pharmacological regulation of the endocannabinoid CB1 receptor in Duchenne muscular dystrophy
The regenerative capacity of muscle stem cells is impaired in Duchenne muscular dystrophy (DMD). Here, the authors show that the endocannabinoid receptor CB1 is activated by PAX7 in muscle stem cells, and that pharmacological inhibition of CB1 promotes stem cell activation and ameliorates symptoms i...
Main Authors: | Fabio A. Iannotti, Ester Pagano, Ombretta Guardiola, Simone Adinolfi, Valentina Saccone, Silvia Consalvi, Fabiana Piscitelli, Elisabetta Gazzerro, Giuseppe Busetto, Diego Carrella, Raffaele Capasso, Pier Lorenzo Puri, Gabriella Minchiotti, Vincenzo Di Marzo |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2018-09-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-018-06267-1 |
Similar Items
-
Dysfunctional endocannabinoid CB1 receptor expression and signaling contribute to skeletal muscle cell toxicity induced by simvastatin
by: Hilal Kalkan, et al.
Published: (2023-08-01) -
Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy
by: Hilal Kalkan, et al.
Published: (2023-01-01) -
Preclinical Studies in the mdx Mouse Model of Duchenne Muscular Dystrophy with the Histone Deacetylase Inhibitor Givinostat
by: Silvia Consalvi, et al.
Published: (2013-03-01) -
The influence of the endocannabinoid system on the profibrotic profile of cardiac fibroblasts associated with Duchenne Muscular Dystrophy
by: Lesia Savchenko, et al.
Published: (2024-11-01) -
Structural basis for activation of CB1 by an endocannabinoid analog
by: Kaavya Krishna Kumar, et al.
Published: (2023-05-01)